Facial airflow enhances the benefits of exercise training in people with chronic lung disease: a randomised controlled trial
F2F therapy (facial airflow) is a simple, feasible, low-cost, low-resource nonpharmacological approach to reduce exertional breathlessness during an exercise training programme in people with CLD.
Authors
- Bryan Ross (ORCID: https://orcid.org/0000-0001-9974-7216)
- Jean Bourbeau (ORCID: https://orcid.org/0000-0002-7649-038X)
- Magnus Per Ekström (ORCID: https://orcid.org/0000-0002-7227-5113)
- Hayley Lewthwaite (ORCID: https://orcid.org/0000-0002-5212-2937)
- Andreas von Leupoldt (ORCID: https://orcid.org/0000-0001-8539-8131)
- Rachelle Aucoin (ORCID: https://orcid.org/0000-0003-0392-5802)
- Dennis Jensen (ORCID: https://orcid.org/0000-0001-7156-5103)
- Dan Nguyen
Institutions
- Lund University (SE)
- Hunter Water (AU)
- McGill University Health Centre (CA)
- McGill University (CA)
- KU Leuven (BE)
Publication Details
- Journal
- European Respiratory Journal
- Published
- 2025-11-13
- DOI
- https://doi.org/10.1183/13993003.01109-2025
- Citations
- 1
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 1.52